These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33408299)

  • 1. Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase.
    Yokouchi C; Nishimura Y; Goto H; Sato M; Hidoh Y; Takeuchi K; Ishii Y
    J Toxicol Sci; 2021; 46(1):31-42. PubMed ID: 33408299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of fatty liver in a rat model by enhancing N
    Takeuchi K; Yokouchi C; Goto H; Umehara K; Yamada H; Ishii Y
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):203-210. PubMed ID: 30446221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP
    Mejía SÁ; Gutman LAB; Camarillo CO; Navarro RM; Becerra MCS; Santana LD; Cruz M; Pérez EH; Flores MD
    Eur J Pharmacol; 2018 Jan; 818():499-507. PubMed ID: 29069580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological doses of nicotinic acid and nicotinamide are independently metabolized in rats.
    Shibata K; Fukuwatari T; Suzuki C
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(2):86-93. PubMed ID: 24975217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes.
    Loza-Medrano SS; Baiza-Gutman LA; Manuel-Apolinar L; García-Macedo R; Damasio-Santana L; Martínez-Mar OA; Sánchez-Becerra MC; Cruz-López M; Ibáñez-Hernández MA; Díaz-Flores M
    Mol Biol Rep; 2020 Jan; 47(1):337-351. PubMed ID: 31650383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.
    Varela-Rey M; Martínez-López N; Fernández-Ramos D; Embade N; Calvisi DF; Woodhoo A; Rodríguez J; Fraga MF; Julve J; Rodríguez-Millán E; Frades I; Torres L; Luka Z; Wagner C; Esteller M; Lu SC; Martínez-Chantar ML; Mato JM
    Hepatology; 2010 Jul; 52(1):105-14. PubMed ID: 20578266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic content of S-adenosylmethionine, S-adenosylhomocysteine and glutathione in rats receiving treatments modulating methyl donor availability.
    Henning SM; McKee RW; Swendseid ME
    J Nutr; 1989 Oct; 119(10):1478-82. PubMed ID: 2531221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic fates of nicotinamide, NAD+ and NADH administered orally and intraperitoneally; characterization of oral NADH.
    Kimura N; Fukuwatari T; Sasaki R; Shibata K
    J Nutr Sci Vitaminol (Tokyo); 2006 Apr; 52(2):142-8. PubMed ID: 16802695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide overload may play a role in the development of type 2 diabetes.
    Zhou SS; Li D; Sun WP; Guo M; Lun YZ; Zhou YM; Xiao FC; Jing LX; Sun SX; Zhang LB; Luo N; Bian FN; Zou W; Dong LB; Zhao ZG; Li SF; Gong XJ; Yu ZG; Sun CB; Zheng CL; Jiang DJ; Li ZN
    World J Gastroenterol; 2009 Dec; 15(45):5674-84. PubMed ID: 19960564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration.
    Barak AJ; Beckenhauer HC; Junnila M; Tuma DJ
    Alcohol Clin Exp Res; 1993 Jun; 17(3):552-5. PubMed ID: 8333583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of nicotinamide differs due to an intake of nicotinamide.
    Shibata K; Shimada H; Taguchi H
    Biosci Biotechnol Biochem; 1996 Jul; 60(7):1204-6. PubMed ID: 8782418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
    Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
    Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation.
    An HJ; Lee B; Kim SM; Kim DH; Chung KW; Ha SG; Park KC; Park YJ; Kim SJ; Yun HY; Chun P; Yu BP; Moon HR; Chung HY
    Biol Pharm Bull; 2018; 41(1):29-35. PubMed ID: 29311481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary egg white protein hydrolysate improves orotic acid-induced fatty liver in rats by promoting hepatic phospholipid synthesis and microsomal triglyceride transfer protein expression.
    Jiang Z; Kimura Y; Shirouchi B; Tanaka Y; Tsai WT; Yuan X; Sato M
    J Nutr Biochem; 2021 Dec; 98():108820. PubMed ID: 34273531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet.
    Cho SJ; Kim SB; Cho HJ; Chong S; Chung SJ; Kang IM; Lee JI; Yoon IS; Kim DD
    J Agric Food Chem; 2016 Jul; 64(27):5598-606. PubMed ID: 27321734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of betaine-homocysteine S-methyltransferase in rats causes hyperhomocysteinemia and reduces liver cystathionine β-synthase activity and methylation capacity.
    Strakova J; Gupta S; Kruger WD; Dilger RN; Tryon K; Li L; Garrow TA
    Nutr Res; 2011 Jul; 31(7):563-71. PubMed ID: 21840473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
    Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
    J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD
    Komatsu M; Kanda T; Urai H; Kurokochi A; Kitahama R; Shigaki S; Ono T; Yukioka H; Hasegawa K; Tokuyama H; Kawabe H; Wakino S; Itoh H
    Sci Rep; 2018 Jun; 8(1):8637. PubMed ID: 29872122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.
    Pascale RM; Simile MM; Calvisi DF; Feo CF; Feo F
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation.
    Hai Y; Zuo L; Wang M; Zhang R; Wang M; Ren L; Yang C; Wang J
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.